Assenagon Asset Management S.A. Opti Nose, Inc. Transaction History

Assenagon Asset Management S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$0.82 - $1.44 $8,947 - $15,711	-10,911 Reduced 12.53%	76,185 $79,000
Q1 2024 Apr 24, 2024	BUY	$1.17 - $1.94 $59,274 - $98,284	50,662 Added 139.05%	87,096 $127,000
Q4 2023 Jan 17, 2024	BUY	$1.02 - $1.47 $37,162 - $53,557	36,434 New	36,434 $46,000
Q2 2022 Jul 27, 2022	SELL	$1.76 - $3.82 $120,966 - $262,552	-68,731 Reduced 80.25%	16,911 $62,000
Q1 2022 Apr 25, 2022	BUY	$1.77 - $2.93 $151,586 - $250,931	85,642 New	85,642 $212,000
Q2 2021 Jul 15, 2021	SELL	$2.91 - $3.83 $269,908 - $355,240	-92,752 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$3.47 - $4.75 $321,849 - $440,572	92,752 New	92,752 $342,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.